Kenan Cehic

Array ( [id] => 5496606 [patent_doc_number] => 20090264634 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'SEQUENCES CHARACTERISTIC OF HYPOXIA-REGULATED GENE TRANSCRIPTION' [patent_app_type] => utility [patent_app_number] => 12/269722 [patent_app_country] => US [patent_app_date] => 2008-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 31426 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20090264634.pdf [firstpage_image] =>[orig_patent_app_number] => 12269722 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5474290 [patent_doc_number] => 20090247456 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy' [patent_app_type] => utility [patent_app_number] => 12/157962 [patent_app_country] => US [patent_app_date] => 2008-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 65 [patent_figures_cnt] => 65 [patent_no_of_words] => 28504 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20090247456.pdf [firstpage_image] =>[orig_patent_app_number] => 12157962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4771371 [patent_doc_number] => 20080057029 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-06 [patent_title] => 'Cancer immunotherapy using autologous tumor cells combined with cells expressing a membrane cytokine' [patent_app_type] => utility [patent_app_number] => 11/897993 [patent_app_country] => US [patent_app_date] => 2007-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 23635 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20080057029.pdf [firstpage_image] =>[orig_patent_app_number] => 11897993 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4938425 [patent_doc_number] => 20080075744 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-27 [patent_title] => 'Pharmaceutical composition for cancer treatment containing cells that express a membrane cytokine' [patent_app_type] => utility [patent_app_number] => 11/824480 [patent_app_country] => US [patent_app_date] => 2007-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 23701 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20080075744.pdf [firstpage_image] =>[orig_patent_app_number] => 11824480 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 141573 [patent_doc_number] => 07691566 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-06 [patent_title] => 'Compositions and methods for treatment of cancer' [patent_app_type] => utility [patent_app_number] => 11/538881 [patent_app_country] => US [patent_app_date] => 2006-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 27 [patent_no_of_words] => 45107 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/691/07691566.pdf [firstpage_image] =>[orig_patent_app_number] => 11538881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5079183 [patent_doc_number] => 20070122407 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-31 [patent_title] => 'ISOLATED NUCLEIC ACIDS, VECTORS AND HOST CELLS ENCODING ErbB3 ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 11/534830 [patent_app_country] => US [patent_app_date] => 2006-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 19647 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20070122407.pdf [firstpage_image] =>[orig_patent_app_number] => 11534830 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7351436 [patent_doc_number] => 20040248830 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Agents that regulate apoptosis' [patent_app_type] => new [patent_app_number] => 10/478019 [patent_app_country] => US [patent_app_date] => 2004-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 15784 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20040248830.pdf [firstpage_image] =>[orig_patent_app_number] => 10478019 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 931226 [patent_doc_number] => 06979730 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-12-27 [patent_title] => 'Nucleic acids encoding prostate stem cell antigen' [patent_app_type] => utility [patent_app_number] => 10/374381 [patent_app_country] => US [patent_app_date] => 2003-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 69 [patent_figures_cnt] => 90 [patent_no_of_words] => 45959 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/979/06979730.pdf [firstpage_image] =>[orig_patent_app_number] => 10374381 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7432305 [patent_doc_number] => 20040002086 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-01 [patent_title] => 'Monoclonal antibody for Nkx3.1 and method for detecting the same' [patent_app_type] => new [patent_app_number] => 10/366990 [patent_app_country] => US [patent_app_date] => 2003-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7333 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20040002086.pdf [firstpage_image] =>[orig_patent_app_number] => 10366990 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 793275 [patent_doc_number] => 06982321 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-01-03 [patent_title] => 'Altered antibodies' [patent_app_type] => utility [patent_app_number] => 10/351748 [patent_app_country] => US [patent_app_date] => 2003-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 35 [patent_no_of_words] => 14760 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/982/06982321.pdf [firstpage_image] =>[orig_patent_app_number] => 10351748 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 793275 [patent_doc_number] => 06982321 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-01-03 [patent_title] => 'Altered antibodies' [patent_app_type] => utility [patent_app_number] => 10/351748 [patent_app_country] => US [patent_app_date] => 2003-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 35 [patent_no_of_words] => 14760 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/982/06982321.pdf [firstpage_image] =>[orig_patent_app_number] => 10351748 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 946690 [patent_doc_number] => 06965024 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-11-15 [patent_title] => 'Process for producing humanized chimera antibody' [patent_app_type] => utility [patent_app_number] => 10/265713 [patent_app_country] => US [patent_app_date] => 2002-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 38 [patent_no_of_words] => 20361 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/965/06965024.pdf [firstpage_image] =>[orig_patent_app_number] => 10265713 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 951241 [patent_doc_number] => 06960443 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-11-01 [patent_title] => 'Methods of detecting prostate stem cell antigen in cancer' [patent_app_type] => utility [patent_app_number] => 10/224720 [patent_app_country] => US [patent_app_date] => 2002-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 61 [patent_figures_cnt] => 80 [patent_no_of_words] => 41290 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/960/06960443.pdf [firstpage_image] =>[orig_patent_app_number] => 10224720 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6813209 [patent_doc_number] => 20030072759 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-17 [patent_title] => 'Immunotherapy of tumor with monoclonal antibody against the 17-1A antigen' [patent_app_type] => new [patent_app_number] => 10/197292 [patent_app_country] => US [patent_app_date] => 2002-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5395 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20030072759.pdf [firstpage_image] =>[orig_patent_app_number] => 10197292 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6519169 [patent_doc_number] => 20020192211 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'Method of treating tumor cells by inhibiting growth factor receptor function' [patent_app_type] => new [patent_app_number] => 10/174806 [patent_app_country] => US [patent_app_date] => 2002-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10548 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20020192211.pdf [firstpage_image] =>[orig_patent_app_number] => 10174806 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6847709 [patent_doc_number] => 20030166876 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Method of treating cancer including administering a human chimeric antibody specific for the ganglioside GD3' [patent_app_type] => new [patent_app_number] => 10/166626 [patent_app_country] => US [patent_app_date] => 2002-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 20441 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20030166876.pdf [firstpage_image] =>[orig_patent_app_number] => 10166626 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 938495 [patent_doc_number] => 06972324 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-12-06 [patent_title] => 'Antibodies specific for CD44v6' [patent_app_type] => utility [patent_app_number] => 10/147849 [patent_app_country] => US [patent_app_date] => 2002-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 39231 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/972/06972324.pdf [firstpage_image] =>[orig_patent_app_number] => 10147849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6642466 [patent_doc_number] => 20030103968 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Use of alpha specific antibody BIBH1 in the treatment of cancer' [patent_app_type] => new [patent_app_number] => 10/121464 [patent_app_country] => US [patent_app_date] => 2002-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 15555 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20030103968.pdf [firstpage_image] =>[orig_patent_app_number] => 10121464 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 975751 [patent_doc_number] => 06933368 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-08-23 [patent_title] => 'Increasing antibody affinity by altering glycosylation of immunoglobulin variable region' [patent_app_type] => utility [patent_app_number] => 10/084825 [patent_app_country] => US [patent_app_date] => 2002-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 8180 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/933/06933368.pdf [firstpage_image] =>[orig_patent_app_number] => 10084825 [rel_patent_id] =>[rel_patent_doc_number] =>)